March 25, 2016

Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015)

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

PDE5 inhibitors remain a first-line treatment option because of their excellent efficacy and safety profile. This class of drugs is continually developed with new molecules and new formulations. Intracavernosal injections continue to be an established treatment modality, and intraurethral and topical alprostadil provide an alternative, less invasive treatment option.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Hatzimouratidis et al. (Fri,) studied this question.

synapsesocial.com/papers/69dc7826f3d3790cb713352a https://doi.org/https://doi.org/10.1016/j.jsxm.2016.01.016

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Sildenafil for Treatment of Erectile Dysfunction in Men With Diabetes1999 · 619 citations
2On-demand IC351 (Cialis™) enhances erectile function in patients with erectile dysfunction2001 · 214 citations
3Metabolism and excretion of 5‐ethyl‐2‐{5‐[4‐(2‐hydroxyethyl)piperazine‐1‐sulfonyl]‐2‐propoxyphenyl}‐7‐propyl‐3,5‐dihydropyrrolo[3,2‐ <i>d</i> ]‐pyrimidin‐4‐one (SK3530) in rats2007 · 40 citations
4SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction2013 · 215 citations
5The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction2010 · 45 citations

Preguntar a la IA

Me gusta

Guardar